Upgrade

Rallybio Corporation

RLYB

Last
$17.02
Day
+0.2%
1y
+283.8%
5y
-89.1%
52w
-3.3%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0526d
EMA 21
16.94
EMA 50
16.66
EMA 200
13.13
20d high
-1.5%
5y high
-89.9%
5y range
9th
Website · 7 employees · United States

Positions held

Your positions

RLYB isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
20
Hold
swing
Signal
Buy
Target
$18.12
Stop
$16.43
Stop distance
3.5%
Target vs last
+6.5%

Fundamentals

Market cap$90.26MEnterprise value-$2.62MTrailing P/E2.12Forward P/E-3.15
PEG—Price / book0.95Beta-0.71Dividend yield0.00%
Revenue growth—Earnings growth—Gross margin0.0%Operating margin-39.4%
Profit margin70.5%ROE64.9%ROA-21.3%Debt / equity—
Current ratio27.27Free cash flow-$14.29MAnalyst recommendationnoneMean target—
52w high$17.5752w low$3.67

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.0M$0.2M$0.2M$0.2M$0.2M—
Op margin—-4119.3%-2888.3%-3266.5%-4743.9%—
Net income$43.7M-$8.3M-$5.9M$16.0M-$9.7M—
Gross margin——————
Gross profit——————
Operating income-$5.7M-$8.7M-$6.4M-$6.9M-$10.1M—
  • Revenue -100% vs prior quarter ($0 vs $0.2M).
  • Operating margin compressed to -4119.3%.

Yearly (6y)

20252024202320222021
Revenue$0.9M$0.6M$0.0M$0.0M—
Op margin-3853.6%-9511.9%———
Net income-$9.0M-$57.8M-$74.6M-$66.7M—
Gross margin—————
Gross profit—————
Operating income-$33.1M-$60.5M-$78.9M-$67.9M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

No headlines.

RLYB · daily+0.4% over 13 sessions
Close EMA21 EMA50 EMA200
16.5216.7116.8917.0817.272026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$10M$4M$17M$30M$44M-4744%-2367%10%2025-Q22025-Q32025-Q42026-Q12026-Q2